Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All News and Research Articles

The agency released its regulatory agenda for continuing to address opioid abuse
Comprised of several working groups, the first meeting of the committee is set for April 2019.
PPL-103 was shown to block dependency qualities in mice.
The members offer multimodal treatments to consider. Draft recommendations have a 90-day public comment period.
Research into the brain is hoped to determine biomarkers for pain response.
New study outcomes in mice suggest that common pain measurement tools may be inadequate.
The agency has paved way for greater access to the opioid overdose-reversal drug.
with Tina L. Doshi, MD, MHS A recent replication and extension study out of Yale University1 further examined potential biases in adult observer ratings of children’s pain. 
Further investigations into instructional interventions and its impact on pain chronification are necessary.
In the prevention of vaso-occlusive crises in sickle cell disease patients, the inhibitor led to fewer rates of healthcare visits
Cognitive behavioral therapy may help those living with fibromyalgia and experiencing insomnia.
In a January 8 NPR segment, Kerry Hawk-Lessard, executive director of Native American Lifelines, explained how the ongoing partial government shutdown is preventing her group from providing health services, including medication-assisted treatment for Opioid Use Disorder, to metropolitan-based American Indians.   The partial government shutdown of 2018-19 is hitting Native communities harder than others.
Consider taking this 9-question online survey regarding best practices for opioid tapering.
close X